Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking

Biomaterials

Volumn 30, Issue 35, 2009, Pages 6780-6787

  Chertok, Beata ^a   David, Allan E ^a,b   Moffat, Bradford A ^c   Yang, Victor C ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Industrial Science and Technology Network Inc   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d TIANJIN UNIVERSITY   (China)

Author keywords

Brain tumors; Cationic magnetic nanoparticles; Drug delivery; Magnetic targeting; Surface masking

Indexed keywords

BRAIN TUMORS; CATIONIC MAGNETIC NANOPARTICLES; FAVORABLE INTERACTIONS; IN-VIVO; LOW-MOLECULAR WEIGHT HEPARINS; MAGNETIC CAPTURE; MAGNETIC NANOPARTICLES; MAGNETIC TARGETING; NANOCARRIERS; ORTHOTOPIC; PROSPECTIVE APPLICATIONS; RODENT BRAIN; SIMPLE METHOD; TUMOR SITE;

DRUG DELIVERY; DRUG INTERACTIONS; IRON OXIDES; MAGNETIC MATERIALS; MAGNETISM; ONCOLOGY; PLASMAS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYSACCHARIDES; TUMORS;

NANOPARTICLES;

LOW MOLECULAR WEIGHT HEPARIN; MACROGOL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RAT; SURFACE PROPERTY;

ADSORPTION; ANIMALS; BRAIN NEOPLASMS; CATIONS; CELL LINE, TUMOR; DRUG CARRIERS; FERRIC COMPOUNDS; MAGNETICS; MALE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; SURFACE PROPERTIES;

RODENTIA;

EID: 70349871400     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.08.040     Document Type: Article

References (28)

1. Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 67 1 (2006) 55-60
2. Alexiou C., Jurgons R., Schmid R.J., Bergemann C., Henke J., Erhardt W., et al. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11 3 (2003) 139-149
3. McBain S., Yiu H., El Haj A., and Dobson J. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection. J Mater Chem 17 24 (2007) 2561-2565
4. Bergemann C., Muller-Schulte D., Oster J., a Brassard L., and Lubbe A. Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications. J Magn Magn Mater 194 1-3 (1999) 45-52
5. Papisov M., Bogdanov A., Schaffer B., Nossiff N., Shen T., Weissleder R., et al. Colloidal magnetic-resonance contrast agents - effect of particle surface on biodistribution. J Magn Magn Mater 122 1-3 (1993) 383-386
6. Mykhaylyk O., Vlaskou D., Tresilwised N., Pithayanukul P., Moller W., and Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. J Magn Magn Mater 311 1 (2007) 275-281
7. Koch A., Reynolds F., Kircher M., Merkle H., Weissleder R., and Josephson L. Uptake and metabolism of a dual fluorochrome tat-nanoparticle in HeLa cells. Bioconjug Chem 14 6 (2003) 1115-1121
8. Campbell R., Fukumura D., Brown E., Mazzola L., Izumi Y., Jain R., et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res 62 23 (2002) 6831-6836
9. Vincent S., Depace D., and Finkelstein S. Distribution of anionic sites on the capillary endothelium in an experimental brain-tumor model. Microcirc Endoth Lym 4 1 (1988) 45-67
10. Weissleder R., Bogdanov A., Neuwelt E.A., and Papisov M. Long-circulating iron-oxides for MR-Imaging. Adv Drug Deliv Rev 16 2-3 (1995) 321-334
11. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9 2 (2002) 102-109
12. Packer R. Brain tumors in children. Arch Neurol 56 4 (1999) 421-425
13. Lam P., and Breakefield X. Potential of gene therapy for brain tumors. Hum Mol Genet 10 7 (2001) 777-787
14. Dandamudi S., and Campbell R. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Biochim Biophys Acta 1768 3 (2007) 427-438
15. Blasberg R.G., and Groothuis D.R. Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13 1 (1986) 70-82
16. Storm G., Belliot S., Daemen T., and Lasic D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17 1 (1995) 31-48
17. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S., Coll J.L., Behr J., et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1 3 (1999) 210-222
18. Rabenstein D. Heparin and heparan sulfate: structure and function. Nat Prod Rep 19 3 (2002) 312-331
19. Liang J.F., Li Y.T., Connell M.E., and Yang V.C. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system. AAPS PharmSci 2 1 (2000) E7
20. Miller G. Use of dinitrosalycilic acid reagent for determination of reducing sugar. Anal Chem 31 3 (1959) 426-428
21. Borch R., Bernstein M., and Durst H. The cyanohydridoborate anion as a selective reducing agent. J Am Chem Soc 93 (1971) 2897-2905
22. Copley A., and Whitney D. The standardization and assay of heparin by the toluidine blue and azure A reactions. J Lab Clin Med 28 (1943) 762-770
23. Sims G., and Snape T. A method for the estimation of polyethylene-glycol in plasma-protein fractions. Anal Biochem 107 1 (1980) 60-63
24. Futami J., Kitazoe M., Maeda T., Nukui E., Sakaguchi M., Kosaka J., et al. Intracellular delivery of proteins into mammalian living cells by polyethylenimine-cationization. J Biosci Bioeng 99 2 (2005) 95-103
25. Ross B., Zhao Y.-J., Neal E., Stegman L., Ercolani M., Ben-Yoseph O., et al. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci U S A 95 (1998) 7012-7017
26. Chertok B., Moffat B., David A., Yu F., Bergemann C., Ross B., et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29 4 (2008) 487-496
27. Brigger I., Morizet J., Laudani L., Aubert G., Appel M., Velasco V., et al. Negative preclinical results with stealth((R)) nanospheres-encapsulated doxorubicin in an orthotopic murine brain tumor model. J Control Release 100 1 (2004) 29-40
28. Wilkins D., and Myers P. Studies on relationship between electrophoretic properties of colloids and their blood clearance and organ distribution in rat. Br J Exp Pathol 47 6 (1966) 568-576